| Metric | Value (₹ Cr) | Q1 FY26 | Q2 FY25 |
|---|---|---|---|
| Revenue | 929.11 | 5.7% | 19.6% |
| Total Income | 958.49 | 5.8% | 19.5% |
| Expenditure | 872.76 | 2.9% | 15.3% |
| PBT | 85.72 | 49.3% | 88.3% |
| Net Profit | 74.36 | 47.9% | 75.3% |
| OPM | 14.30% | 7.56pp | 20.68pp |
| NPM | 7.76% | 6.28pp | 2.47pp |
| EPS | 8.24 | 48.0% | 75.3% |
Sharda Cropchem Q2 FY 2025-26: Revenue at INR929 crores, 71% Y-o-Y growth in EBITDA
06 Nov 2025 · 6 Nov 2025, 05:33 pm
Summary
Sharda Cropchem Limited has reported its Q2 FY 2025-26 financial results with a revenue of INR929 crores, representing a 20% year-on-year growth. The agrochemical business grew by 27% year-on-year, while the non-agrochemical business degrew by 11%. Gross margin stood at 34.5% in Q2 FY '26, with EBITDA growing by 71% to INR139 crores. PAT stood at INR74 crores, showing a 75% growth on a year-on-year basis. The company remains debt-free with cash, bank, and liquid investments of INR794 crores as of 30 September 2025.
Key Highlights
- 1
Revenue at INR929 crores, a 20% year-on-year increase
- 2
Agrochemical business grew by 27% year-on-year
- 3
Non-agrochemical business degrew by 11%
- 4
Gross margin at 34.5% in Q2 FY '26
- 5
EBITDA grew by 71% to INR139 crores
- 6
PAT at INR74 crores, 75% year-on-year growth
- 7
Debt-free company with INR794 crores cash, bank, and liquid investments
Management Comments
Mr. R. V. Bubna
I would say 15% growth in Europe is very normal and doesn't require any further comments.
Mr. R. V. Bubna
The forex loss has been very small, and it is notional. It is not a real loss. This is attributable only to the euro-dollar exchange rate because all our sourcing is in dollars and major sales in Europe, which is in euros.
Sharda Cropchem Limited
Volume growth in our agrochemical segment and better pricing were observed.
Informational and educational content only. Not investment advice.